Health Blueprint

Back to Longevity News

News summary

CRISPR could help doctors attack blood cancer without destroying healthy cells

Source: Science Daily - Health & Medicine • Published: 25 Sept 2026, 13:13

Summarized by Masters of Longevity from Science Daily - Health & Medicine.

CRISPR-based transplant research that explores protecting healthy donor blood cells so doctors can safely deliver targeted leukemia therapies. Read to learn what kind of clinical trial and approach the article describes.

CRISPR could help doctors attack blood cancer without destroying healthy cells
Key Takeaways
  • Researchers transplanted CD33-deleted allogeneic hematopoietic stem cells into 30 patients, and the edited cells successfully engrafted.
  • The CD33 deletion appeared to protect donor-derived blood cells from subsequent CD33-targeted therapy in treated patients.
  • The trial reported remission in at least one TP53-mutant acute myeloid leukemia patient following the edited graft and donor-derived anti-CD33 CAR-T therapy.
Read the full article at Science Daily - Health & Medicine ↗

Continue exploring

Recommended MoL Picks

MoL PickNucleotides and Longevity: Is the Evidence Ready?They help build DNA and keep cells working. Early human studies make nucleotide supplements interesting—but leave important questions about healthy ageing unanswered. Yet.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickCan Doctors Be Trained for the Longevity Era?A new global survey suggests that healthy longevity medicine education can change how physicians think and talk about ageing. But the evidence also highlights how much work remains before a rapidly growing field becomes routine clinical care.